Bristol-Myers Squibb Total Debt vs. Number of Shares Shorted

BMYMP
 Stock
  

USD 1,287  0.00  0.00%   

For Bristol-Myers Squibb profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bristol-Myers Squibb to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bristol-Myers Squibb utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bristol-Myers Squibb's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bristol-Myers Squibb over time as well as its relative position and ranking within its peers. Continue to Trending Equities.
  
Please note, there is a significant difference between Bristol-Myers Squibb's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol-Myers Squibb value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bristol-Myers Squibb Number of Shares Shorted vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bristol-Myers Squibb's current stock value. Our valuation model uses many indicators to compare Bristol-Myers Squibb value to that of its competitors to determine the firm's financial worth.
Bristol-Myers Squibb is the top company in total debt category among related companies. It is number one stock in number of shares shorted category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bristol-Myers Squibb by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bristol-Myers Squibb's OTC Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bristol-Myers Squibb's earnings, one of the primary drivers of an investment's value.

Bristol-Myers Total Debt vs. Competition

Bristol-Myers Squibb is the top company in total debt category among related companies. Total debt of Drug Manufacturers - Major industry is currently estimated at about 129.37 Billion. Bristol-Myers Squibb totals roughly 39.6 Billion in total debt claiming about 31% of equities under Drug Manufacturers - Major industry.
Total debt  Capitalization  Valuation  Workforce  Revenue

Bristol-Myers Number of Shares Shorted vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Bristol-Myers Squibb 
Total Debt 
 = 
Bonds 
+  
Notes 
39.6 B
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Bristol-Myers Squibb 
Shares Shorted 
 = 
Shorted by Public 
by Institutions 
null
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Bristol-Myers Number of Shares Shorted Comparison

Bristol-Myers Squibb is currently under evaluation in number of shares shorted category among related companies.

Bristol-Myers Squibb Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bristol-Myers Squibb, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bristol-Myers Squibb will eventually generate negative long term returns. The profitability progress is the general direction of Bristol-Myers Squibb's change in net profit over the period of time. It can combine multiple indicators of Bristol-Myers Squibb, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.

Bristol-Myers Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bristol-Myers Squibb. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bristol-Myers Squibb position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bristol-Myers Squibb's important profitability drivers and their relationship over time.

Use Bristol-Myers Squibb in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol-Myers Squibb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will appreciate offsetting losses from the drop in the long position's value.

Bristol-Myers Squibb Pair Trading

Bristol-Myers Squibb Pair Trading Analysis

The ability to find closely correlated positions to Bristol-Myers Squibb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol-Myers Squibb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol-Myers Squibb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol-Myers Squibb to buy it.
The correlation of Bristol-Myers Squibb is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol-Myers Squibb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol-Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol-Myers Squibb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bristol-Myers Squibb position

In addition to having Bristol-Myers Squibb in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Thematic Idea Now

Small Growth
Small Growth Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Theme or any other thematic opportunities.
View All  Next Launch
Continue to Trending Equities. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for analysis

When running Bristol-Myers Squibb price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
To fully project Bristol-Myers Squibb's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bristol-Myers Squibb at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bristol-Myers Squibb's income statement, its balance sheet, and the statement of cash flows.
Potential Bristol-Myers Squibb investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bristol-Myers Squibb investors may work on each financial statement separately, they are all related. The changes in Bristol-Myers Squibb's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bristol-Myers Squibb's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.